Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Current Status and Scope of Lymph Node Micrometastasis in Gastric Cancer

  • Lee, Chang Min (Department of Gastroenterologic Surgery, Korea University Medical Center) ;
  • Park, Sung-Soo (Department of Gastroenterologic Surgery, Korea University Medical Center) ;
  • Kim, Jong-Han (Department of Gastroenterologic Surgery, Korea University Medical Center)
  • Received : 2014.12.14
  • Accepted : 2015.01.13
  • Published : 2015.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, lymph node micrometastasis has been evaluated for its prognostic value in gastric cancer. Lymph node micrometastasis cannot be detected via a usual pathologic examination, but it can be detected by using some other techniques including immunohistochemistry and reverse transcription-polymerase chain reaction assay. With the development of such diagnostic techniques, the detection rate of lymph node micrometastasis is constantly increasing. Although the prognostic value of lymph node micrometastasis remains debatable, its clinical impact is apparently remarkable in both early and advanced gastric cancer. At present, studies on the prognostic value of lymph node micrometastasis are evolving to overcome its current limitations and extend the scope of its application.

Keywords

References

  1. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449-461. https://doi.org/10.1097/00000658-199810000-00002
  2. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003;10:1077-1085. https://doi.org/10.1245/ASO.2003.03.520
  3. Kwon SJ, Kim GS. Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach. Br J Surg 1996;83:1600-1603. https://doi.org/10.1002/bjs.1800831136
  4. Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, Korenaga D, et al. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer 1992;70:392-395. https://doi.org/10.1002/1097-0142(19920715)70:2<392::AID-CNCR2820700204>3.0.CO;2-P
  5. Maehara Y, Oshiro T, Endo K, Baba H, Oda S, Ichiyoshi Y, et al. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397-402. https://doi.org/10.1016/S0039-6060(96)80138-3
  6. Siewert JR, Kestlmeier R, Busch R, Bottcher K, Roder JD, Muller J, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-1147. https://doi.org/10.1002/bjs.1800830836
  7. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069-1076. https://doi.org/10.1002/(SICI)1097-0142(19970315)79:6<1069::AID-CNCR3>3.0.CO;2-B
  8. Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol 2008;22:835-839. https://doi.org/10.1155/2008/761821
  9. Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, Tsujitani S, et al. Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol 2010;101:622-625. https://doi.org/10.1002/jso.21562
  10. Ru Y, Zhang L, Chen Q, Gao SG, Wang GP, Qu ZF, et al. Detection and clinical significance of lymph node micrometastasis in gastric cardia adenocarcinoma. J Int Med Res 2012;40:293-299. https://doi.org/10.1177/147323001204000129
  11. Yonemura Y, Endo Y, Hayashi I, Kawamura T, Yun HY, Bandou E. Proliferative activity of micrometastases in the lymph nodes of patients with gastric cancer. Br J Surg 2007;94:731-736. https://doi.org/10.1002/bjs.5604
  12. Choi HJ, Kim YK, Kim YH, Kim SS, Hong SH. Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma. Ann Surg Oncol 2002;9:13-19. https://doi.org/10.1245/aso.2002.9.1.13
  13. Cai J, Ikeguchi M, Maeta M, Kaibara N. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery 2000;127:32-39. https://doi.org/10.1067/msy.2000.100881
  14. Lee E, Chae Y, Kim I, Choi J, Yeom B, Leong AS. Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer 2002;94:2867-2873. https://doi.org/10.1002/cncr.10562
  15. Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 2002;9:771-774. https://doi.org/10.1007/BF02574499
  16. Hata M, Machi J, Mamou J, Yanagihara ET, Saegusa-Beecroft E, Kobayashi GK, et al. Entire-volume serial histological examination for detection of micrometastases in lymph nodes of colorectal cancers. Pathol Oncol Res 2011;17:835-841. https://doi.org/10.1007/s12253-011-9390-y
  17. Matsumoto M, Natsugoe S, Ishigami S, Nakashima S, Nakajo A, Miyazono F, et al. Lymph node micrometastasis and lymphatic mapping determined by reverse transcriptasepolymerase chain reaction in pN0 gastric carcinoma. Surgery 2002;131:630-635. https://doi.org/10.1067/msy.2002.124632
  18. Sobin LH, Wittekind C, International Union against Cancer. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss, 2002:xxiii, 239.
  19. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. TNM classification of malignant tumours. 7th ed. Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell, 2010:xx, 309.
  20. Arigami T, Uenosono Y, Yanagita S, Nakajo A, Ishigami S, Okumura H, et al. Clinical significance of lymph node micrometastasis in gastric cancer. Ann Surg Oncol 2013;20:515-521. https://doi.org/10.1245/s10434-012-2355-x
  21. Kashimura H, Ajioka Y, Watanabe H, Nishikura K, Iiri T, Asakura H. Risk factors for nodal micrometastasis of submucosal gastric carcinoma: assessment of indications for endoscopic treatment. Gastric Cancer 1999;2:33-39. https://doi.org/10.1007/s101200050018
  22. Harrison LE, Choe JK, Goldstein M, Meridian A, Kim SH, Clarke K. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J Surg Oncol 2000;73:153-157. https://doi.org/10.1002/(SICI)1096-9098(200003)73:3<153::AID-JSO8>3.0.CO;2-4
  23. Okada Y, Fujiwara Y, Yamamoto H, Sugita Y, Yasuda T, Doki Y, et al. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay. Cancer 2001;92:2056-2064. https://doi.org/10.1002/1097-0142(20011015)92:8<2056::AID-CNCR1545>3.0.CO;2-L
  24. Nakajo A, Natsugoe S, Ishigami S, Matsumoto M, Nakashima S, Hokita S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol 2001;8:158-162. https://doi.org/10.1007/s10434-001-0158-6
  25. Morgagni P, Saragoni L, Scarpi E, Zattini PS, Zaccaroni A, Morgagni D, et al. Lymph node micrometastases in early gastric cancer and their impact on prognosis. World J Surg 2003;27:558-561. https://doi.org/10.1007/s00268-003-6797-y
  26. Arigami T, Natsugoe S, Uenosono Y, Arima H, Mataki Y, Ehi K, et al. Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer 2005;93:688-693. https://doi.org/10.1038/sj.bjc.6602739
  27. Sonoda H, Yamamoto K, Kushima R, Yamamoto H, Naitoh H, Okabe H, et al. Detection of lymph node micrometastasis in pN0 early gastric cancer: efficacy of duplex RT-PCR with MUC2 and TFF1 in mucosal cancer. Oncol Rep 2006;16:411-416.
  28. Wu ZY, Li JH, Zhan WH, He YL, Wan J. Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol 2007;13:4122-4125. https://doi.org/10.3748/wjg.v13.i30.4122
  29. Ishii K, Kinami S, Funaki K, Fujita H, Ninomiya I, Fushida S, et al. Detection of sentinel and non-sentinel lymph node micrometastases by complete serial sectioning and immunohistochemical analysis for gastric cancer. J Exp Clin Cancer Res 2008;27:7. https://doi.org/10.1186/1756-9966-27-7
  30. Cao L, Hu X, Zhang Y, Huang G. Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer. J Surg Oncol 2011;103:53-56. https://doi.org/10.1002/jso.21755
  31. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24. https://doi.org/10.1016/0092-8674(82)90400-7
  32. Yamamoto N, Kato Y, Yanagisawa A, Ohta H, Takahashi T, Kitagawa T. Predictive value of genetic diagnosis for cancer micrometastasis: histologic and experimental appraisal. Cancer 1997;80:1393-1398. https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8<1393::AID-CNCR5>3.0.CO;2-G
  33. Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Multivariate prognostic study on large gastric cancer. J Surg Oncol 2007;96:14-18. https://doi.org/10.1002/jso.20631
  34. Al-Moundhri MS, Al-Bahrani B, Burney IA, Nirmala V, Al-Madhani A, Al-Mawaly K, et al. The prognostic determinants of gastric cancer treatment outcome in Omani Arab patients. Oncology 2006;70:90-96. https://doi.org/10.1159/000092584
  35. Dicken BJ, Saunders LD, Jhangri GS, de Gara C, Cass C, Andrews S, et al. Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol 2004;11:629-635. https://doi.org/10.1245/ASO.2004.09.002
  36. Isozaki H, Okajima K, Fujii K. Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy. Hepatogastroenterology 1997;44:1133-1136.
  37. Kikuchi Y, Tsuchiya A, Ando Y, Yoshida T, Takenosita S. Immunohistochemical detection of lymph node microinvolvement in node-negative gastric cancer. Gastric Cancer 1999;2:173-178. https://doi.org/10.1007/s101200050042
  38. Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH. Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol 2009;35:409-414. https://doi.org/10.1016/j.ejso.2008.05.004
  39. Bostick PJ, Morton DL, Turner RR, Huynh KT, Wang HJ, Elashoff R, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptasepolymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999;17:3238-3244. https://doi.org/10.1200/JCO.1999.17.10.3238
  40. Bostick PJ, Huynh KT, Sarantou T, Turner RR, Qi K, Giuliano AE, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer 1998;79:645-651. https://doi.org/10.1002/(SICI)1097-0215(19981218)79:6<645::AID-IJC16>3.0.CO;2-R
  41. Hoon DS, Bostick P, Kuo C, Okamoto T, Wang HJ, Elashoff R, et al. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res 2000;60:2253-2257.
  42. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigenexpressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-729. https://doi.org/10.1200/JCO.1994.12.4.725
  43. Kubota K, Nakanishi H, Hiki N, Shimizu N, Tsuji E, Yamaguchi H, et al. Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry. Int J Cancer 2003;105:136-143. https://doi.org/10.1002/ijc.11031
  44. Ruud P, Fodstad O, Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 1999;80:119-125. https://doi.org/10.1002/(SICI)1097-0215(19990105)80:1<119::AID-IJC22>3.0.CO;2-X
  45. Kuo CT, Hoon DS, Takeuchi H, Turner R, Wang HJ, Morton DL, et al. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol 2003;21:3566-3572. https://doi.org/10.1200/JCO.2003.01.063
  46. Yaguchi Y, Sugasawa H, Tsujimoto H, Takata H, Nakabayashi K, Ichikura T, et al. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer. Ann Surg Oncol 2011;18:2289-2296. https://doi.org/10.1245/s10434-011-1591-9
  47. Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007;13:4807-4816. https://doi.org/10.1158/1078-0432.CCR-06-2512
  48. Yanagita S, Natsugoe S, Uenosono Y, Arigami T, Funasako Y, Hirata M, et al. The utility of rapid diagnosis of lymph node metastasis in gastric cancer using a multiplex real-time reverse transcription polymerase chain reaction assay. Oncology 2009;77:205-211. https://doi.org/10.1159/000236020
  49. Fukagawa T, Sasako M, Mann GB, Sano T, Katai H, Maruyama K, et al. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer 2001;92:753-760. https://doi.org/10.1002/1097-0142(20010815)92:4<753::AID-CNCR1379>3.0.CO;2-5
  50. Wang J, Yu JC, Kang WM, Wang WZ, Liu YQ, Gu P. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer. Ann Surg Oncol 2012;19:1529-1534. https://doi.org/10.1245/s10434-011-2115-3
  51. Kim JH, Park JM, Jung CW, Park SS, Kim SJ, Mok YJ, et al. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol 2008;97:125-130. https://doi.org/10.1002/jso.20937
  52. Morgagni P, Saragoni L, Folli S, Gaudio M, Scarpi E, Bazzocchi F, et al. Lymph node micrometastases in patients with early gastric cancer: experience with 139 patients. Ann Surg Oncol 2001;8:170-174. https://doi.org/10.1007/s10434-001-0170-x
  53. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001;48:225-229. https://doi.org/10.1136/gut.48.2.225
  54. Hotta K, Oyama T, Akamatsu T, Tomori A, Hasebe O, Nakamura N, et al. A comparison of outcomes of endoscopic submucosal dissection (ESD) For early gastric neoplasms between high-volume and low-volume centers: multi-center retrospective questionnaire study conducted by the Nagano ESD Study Group. Intern Med 2010;49:253-259. https://doi.org/10.2169/internalmedicine.49.2816
  55. Jee YS, Hwang SH, Rao J, Park DJ, Kim HH, Lee HJ, et al. Safety of extended endoscopic mucosal resection and endoscopic submucosal dissection following the Japanese Gastric Cancer Association treatment guidelines. Br J Surg 2009;96:1157-1161. https://doi.org/10.1002/bjs.6686
  56. Yamaguchi N, Isomoto H, Fukuda E, Ikeda K, Nishiyama H, Akiyama M, et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer by indication criteria. Digestion 2009;80:173-181. https://doi.org/10.1159/000215388
  57. Rosch T. Endosonographic staging of gastric cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995;5:549-557. https://doi.org/10.1016/S1052-5157(18)30420-3
  58. Polkowski M, Palucki J, Wronska E, Szawlowski A, Nasierowska-Guttmejer A, Butruk E. Endosonography versus helical computed tomography for locoregional staging of gastric cancer. Endoscopy 2004;36:617-623. https://doi.org/10.1055/s-2004-814522
  59. Sano T, Hollowood A. Early gastric cancer: diagnosis and less invasive treatments. Scand J Surg 2006;95:249-255. https://doi.org/10.1177/145749690609500407
  60. Aikou T, Higashi H, Natsugoe S, Hokita S, Baba M, Tako S. Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Ann Surg Oncol 2001;8:90S-93S.
  61. Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M. Radio-guided sentinel node detection for gastric cancer. Br J Surg 2002;89:604-608. https://doi.org/10.1046/j.1365-2168.2002.02065.x
  62. Arigami T, Natsugoe S, Uenosono Y, Mataki Y, Ehi K, Higashi H, et al. Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg 2006;243:341-347. https://doi.org/10.1097/01.sla.0000201453.65534.f1
  63. Tajima Y, Yamazaki K, Masuda Y, Kato M, Yasuda D, Aoki T, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer. Ann Surg 2009;249:58-62. https://doi.org/10.1097/SLA.0b013e3181927267
  64. Chao C, Wong SL, Ackermann D, Simpson D, Carter MB, Brown CM, et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg 2001;182:609-615. https://doi.org/10.1016/S0002-9610(01)00794-2
  65. Tanis PJ, Boom RP, Koops HS, Faneyte IF, Peterse JL, Nieweg OE, et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001;8:222-226. https://doi.org/10.1007/s10434-001-0222-2
  66. Lee HS, Lee HE, Park do J, Park YS, Kim HH. Precise pathologic examination decreases the false-negative rate of sentinel lymph node biopsy in gastric cancer. Ann Surg Oncol 2012;19:772-778. https://doi.org/10.1245/s10434-011-2106-4
  67. Saikawa Y, Otani Y, Kitagawa Y, Yoshida M, Wada N, Kubota T, et al. Interim results of sentinel node biopsy during laparoscopic gastrectomy: possible role in function-preserving surgery for early cancer. World J Surg 2006;30:1962-1968. https://doi.org/10.1007/s00268-006-0142-1
  68. Takeuchi H, Kitagawa Y. New sentinel node mapping technologies for early gastric cancer. Ann Surg Oncol 2013;20:522-532. https://doi.org/10.1245/s10434-012-2602-1
  69. Takeuchi H, Oyama T, Kamiya S, Nakamura R, Takahashi T, Wada N, et al. Laparoscopy-assisted proximal gastrectomy with sentinel node mapping for early gastric cancer. World J Surg 2011;35:2463-2471. https://doi.org/10.1007/s00268-011-1223-3
  70. Bok GH, Kim YJ, Jin SY, Chun CG, Lee TH, Kim HG, et al. Endoscopic submucosal dissection with sentinel node navigation surgery for early gastric cancer. Endoscopy 2012;44:953-956. https://doi.org/10.1055/s-0032-1310162
  71. Takeuchi H, Kitagawa Y. Sentinel node navigation surgery in patients with early gastric cancer. Dig Surg 2013;30:104-111. https://doi.org/10.1159/000350875
  72. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010;17:3077-3079. https://doi.org/10.1245/s10434-010-1362-z
  73. Hirata K, Horikoshi N, Aiba K, Okazaki M, Denno R, Sasaki K, et al. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug. Clin Cancer Res 1999;5:2000-2005.
  74. Ohtsu A. Current status and future prospects of chemotherapy for metastatic gastric cancer: a review. Gastric Cancer 2005;8:95-102. https://doi.org/10.1007/s10120-005-0324-9
  75. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008;9:215-221. https://doi.org/10.1016/S1470-2045(08)70035-4
  76. Lee CM, Cho JM, Jang YJ, Park SS, Park SH, Kim SJ, et al. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer. Ann Surg Oncol 2014 [Epub].

Cited by

  1. The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial vol.16, pp.2, 2016, https://doi.org/10.5230/jgc.2016.16.2.105
  2. Current status of lymph node micrometastasis in gastric cancer vol.8, pp.31, 2015, https://doi.org/10.18632/oncotarget.17495
  3. Prognostic Significance of Solitary Lymphnode Metastasis and Micrometastasis in Gastric Cancer vol.5, pp.None, 2015, https://doi.org/10.3389/fsurg.2018.00063
  4. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer vol.25, pp.None, 2015, https://doi.org/10.12659/msm.913558
  5. Performance of Molecular Lymphosonography for Detection and Quantification of Metastatic Involvement in Sentinel Lymph Nodes vol.38, pp.8, 2015, https://doi.org/10.1002/jum.14906
  6. Impact of multisection and immunohistochemistry in lymph node staging of Gastric Carcinoma – Case series vol.10, pp.None, 2020, https://doi.org/10.1038/s41598-020-59000-8
  7. Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment-Oncological and Surgical Perspective vol.13, pp.10, 2015, https://doi.org/10.3390/cancers13102509
  8. Predicting gastric cancer outcome from resected lymph node histopathology images using deep learning vol.12, pp.1, 2021, https://doi.org/10.1038/s41467-021-21674-7